García-Carrasco Mario, Mendoza-Pinto Claudia, Escárcega Ricardo O, Jiménez-Hernández Mario, Etchegaray Morales Ivet, Munguía Realpozo Pamela, Rebollo-Vázquez Jaime, Soto-Vega Elena, Delezé Margarita, Cervera Ricard
Systemic Autoinmune Diseases Research Unit, Hospital General Regional No. 36, IMSS, Puebla, Mexico.
Isr Med Assoc J. 2009 Aug;11(8):486-91.
In recent years the survival of patients with systemic lupus erythematosus has increased markedly. Consequently, long-term complications, such as osteoporosis, are currently of paramount importance. SLE is known to increase the risk of bone fractures, and numerous studies have found that SLE patients have osteoporosis. Of the various risk factors associated with osteoporosis in SLE, disease duration, the use of corticosteroids and chronic disease-related damage are consistently reported, with differences between studies probably due to the different populations studied. The role of chronic inflammation in osteoporosis is also important. On the other hand, little attention has been paid to osteoporotic fractures, especially of the vertebra, which are associated with reduced quality of life, increased mortality rates and increased risk of new vertebral and non-vertebral fractures in the general population.
近年来,系统性红斑狼疮患者的生存率显著提高。因此,诸如骨质疏松症等长期并发症目前至关重要。已知系统性红斑狼疮会增加骨折风险,并且大量研究发现系统性红斑狼疮患者患有骨质疏松症。在系统性红斑狼疮中与骨质疏松症相关的各种风险因素中,疾病持续时间、皮质类固醇的使用以及慢性病相关损害一直有报道,不同研究之间的差异可能归因于所研究的不同人群。慢性炎症在骨质疏松症中的作用也很重要。另一方面,骨质疏松性骨折,尤其是椎体骨折,很少受到关注,而椎体骨折与生活质量下降、死亡率增加以及普通人群中新发椎体和非椎体骨折风险增加有关。